JAK2 and pulmonary fibrosis: Similarly, selective JAK2 tyrosine kinase inhibition by fedratinib attenuated TGF-β- and IL-6-induced myofibroblast activation regulated by JAK2/p-STAT3 as well as reduced bleomycin-induced lung fibrosis in mice in vivo [70].